Trial intelligence / Profile preview

Remimazolam for painless bronchoscopy

ChiCTR2200065977Phase 4Recruiting

Sponsor
Fifth Affiliated Hospital of Southern Medical University
Start
Sep 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of remimazolam in bronchoscopy sedation (4 arms), sponsored by Fifth Affiliated Hospital of Southern Medical University. Primary endpoints: Sedation effect and Cognitive function (MOAA/S). Started Sep 2022; status: recruiting.

02

Drugs

remimazolam
03

Conditions

bronchoscopy sedation

Beyond the preview

Go deeper on ChiCTR2200065977.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2200065977.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call